Explore News By Topic
06/14/2018
New Study Identifies Another Opportunity for Precision Immunotherapy in Prostate Cancer
A new Prostate Cancer Foundation (PCF)-funded study published today in the scientific journal Cell has identified a new subtype of advanced prostate cancer – one which may be treatable with checkpoint immunotherapy, a type of treatment that can produce long-term remissions and even cures in many cancer types, but has... Read More
06/14/2018
Non-coding DNA reveals a route by which advanced prostate cancer resists treatment
More than three quarters of metastatic prostate cancers that resist hormone-blocking therapies may harbor several duplicates of both the gene for a treatment resistance factor called the androgen receptor (AR) and of a never-before-seen genetic switch, or enhancer, that boosts the gene's expression. The duplications, as well as epigenetic signs... Read More
06/07/2018
New and More Sensitive Prostate Cancer Imaging on the Near Horizon
At the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, promising results were reported from a phase 2/3 clinical trial testing the accuracy of a new prostate cancer imaging method -- PSMA-PET -- for detecting sites of prostate cancer recurrence. The current standard imaging methods for detecting recurrent or... Read More
Why More Men Are Delaying Treatment for Prostate Cancer
Original article issued by Healthline. When Ben Pfeiffer was diagnosed with prostate cancer in April, his urologist noted in the biopsy report that he was leaning toward recommending that Pfeiffer have his prostate surgically removed. But Pfeiffer, 58, a married construction supervisor from Las Vegas with two grown daughters, said... Read More
06/05/2018
Modell’s Sporting Goods Partners With the Prostate Cancer Foundation During Men’s Health Month to Raise Funds for Prostate Cancer Research
NEW YORK, NY, June 5, 2018 – June is Men’s Health Month and to heighten awareness about a men’s health issue – prostate cancer – Modell’s Sporting Goods will be joining forces with the Prostate Cancer Foundation (PCF) to raise money to advance prostate cancer research. For the fourth consecutive... Read More
Prostate Cancer Foundation’s Statement on Late-Breaking ASCO Presentation Regarding Racial Differences in Prostate Cancer and Call for Greater Diversity in Clinical Trial Participation
JUNE 1, 2018 - Each year three million men in the U.S. battle prostate cancer and on average one in nine men will be diagnosed in their lifetime. However, there are significant racial disparities about the impact of the disease, particularly for men of African descent. Compared to men of... Read More
05/31/2018
The Prostate Cancer Foundation and Major League Baseball are Back In Full Swing To Defeat Prostate Cancer with the 23rd Annual Home Run Challenge
LOS ANGELES, Calif., May 31, 2018 – From June 1 to 17 (Father’s Day), the Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) will team up for the 23rd Annual Home Run Challenge, a national men’s health campaign designed to support research and bring awareness to the fight against... Read More
05/15/2018
VA Healthcare System Successfully Reduces ‘Rush to Treatment’ Rates for Low-Risk Prostate Cancer, Study Shows
May 15, 2018 - Record numbers of American veterans diagnosed with nonaggressive prostate cancer are heeding the advice of international medical experts and opting out of immediate surgery or radiation to treat their cancer. Instead, according to a study led by researchers at NYU School of Medicine, Perlmutter Cancer Center,... Read More
05/09/2018
Prostate Cancer Foundation Statement on U.S. Preventive Services Task Force Updated Prostate Screening Guidelines
Yesterday, the USPSTF updated its 2012 position on prostate cancer screening recommending that clinicians should selectively offer or provide periodic prostate-specific antigen (PSA)–based screening for prostate cancer for men between the ages of 55 to 69 (C recommendation). The USPSTF maintained its recommendation against PSA-based screening for prostate cancer in... Read More
05/08/2018
Clinical trial finds strong promise for new treatment that targets radiation directly to prostate cancer
May 8, 2018 A study published today in Lancet Oncology reported highly promising results from a phase 2 clinical trial testing a new treatment, 177Lu-PSMA-617, which targets radiation directly to prostate cancer. “We show in a prospective study that in men with metastatic castration-resistant prostate cancer who have progressed after standard... Read More